[The effect of biguanides on insulin sensitivity of maturity onset diabetics (author's transl)].
H.‐J. Lisch, S. Sailer, H Braunsteiner
Abstract
H.‐J. Lisch, S. Sailer, H Braunsteiner
Abstract
The effect of short-term treatment with biguanides on the insulin sensitivity (KITT) of maturity onset diabetics was tested by means of an insulin tolerance test. On the basis of their long-term blood glucose response to biguanide therapy, the patients were classified retrospectively as biguanide-responsive subjects (n = 10) and as biguanide-non-responsive subjects (n = 10). Both group showed the typical marked reduction in insulin sensitivity of maturity onset diabetics. After three days of biguanide treatment, a highly significant (p less than 0.001) increase in insulin sensitivity was noted in the group of biguanide responders, which was significantly (p less than 0.02) correlated with their previous blood glucose response to long-term biguanide therapy. In the biguanide non responders, insulin sensitivity was not significantly altered by biguanides. It is suggested that the blood glucose lowering action of biguanides is due, at least in a definite group of patients with maturity onset diabetes, to a reduction of insulin resistance.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The effect of short-term treatment with biguanides on the insulin sensitivity (KITT) of maturity onset diabetics was tested by means of an insulin tolerance test. On the basis of their long-term blood glucose response to biguanide therapy, the patients were classified retrospectively as biguanide-responsive subjects (n = 10) and as biguanide-non-responsive subjects (n = 10). Both group showed the typical marked reduction in insulin sensitivity of maturity onset diabetics. After three days of biguanide treatment, a highly significant (p less than 0.001) increase in insulin sensitivity was noted in the group of biguanide responders, which was significantly (p less than 0.02) correlated with their previous blood glucose response to long-term biguanide therapy. In the biguanide non responders, insulin sensitivity was not significantly altered by biguanides. It is suggested that the blood glucose lowering action of biguanides is due, at least in a definite group of patients with maturity onset diabetes, to a reduction of insulin resistance.
Key concepts: Biguanide, Medicine, Internal medicine, Insulin, Diabetes mellitus, Endocrinology, Insulin resistance, Insulin sensitivity